Psoriasis, a very common systemic inflammatory disease, is potentially disabling from a functional and aesthetic point of view. In recent years, treatments for managing moderate- to-severe psoriasis have significantly evolved since the advent of biologic therapies. Undoubtedly, these latter have favorably impacted the patient quality of life.
Key Words
Psoriasis, biologics, biologic treatments, TNF-alpha inhibitors, interleukin-17 inhibitors, interleukin-23 inhibitors